Purple Biotech PPBT
NASDAQ PPBT
$1.52 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Receivables (2018 - 2022)

Updated

Purple Biotech (PPBT) reported Receivables of $431,000 for Q4 2022, compared with -$316,000 a year earlier.

Analysis

Purple Biotech (PPBT) Receivables (2018 - 2022) Analysis & Trends

Dating back to Q4 2018, Purple Biotech's Receivables record includes 10 quarters.

  • By year, Receivables came in at -$316,000 in FY2021, $500,000 in FY2020 (-67.8%), $1.56 million in FY2019 and -$1.11 million in FY2018.
  • The Q4 2022 figure ranks as the highest quarterly Receivables since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 19.05 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 13.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.68 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 5.06 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 2.13 Bn
10 Purple Biotech 249,214.64 191,214.64 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 431,000.00
Mar 31, 2022 -1.13 Mn
Dec 31, 2021 -316,000.00
Sep 30, 2021 500,000.00
Jun 30, 2021 500,000.00
Mar 31, 2021 500,000.00
Dec 31, 2020 -492,000.00
Jun 30, 2020 1.00 Mn
Dec 31, 2019 1.56 Mn
Dec 31, 2018 -1.11 Mn
API Access

Purple Biotech Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=PPBT&period=max&api_key=YOUR_API_KEY